Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
River Eletec
6666
Fit Easy
212A
JP Stock MarketDetailed Quotes
4980 Dexerials
- 2506.5
- +23.0+0.93%
20min DelayTrading Dec 16 14:44 JST
452.86BMarket Cap20.47P/E (Static)
2522.0High2483.0Low283.50KVolume2484.0Open2483.5Pre Close710.74MTurnover2768.652wk High0.18%Turnover Ratio180.67MShares1339.352wk Low153.82EPS TTM396.25BFloat Cap2768.6Historical High20.47P/E (Static)158.09MShs Float192.3Historical Low122.46EPS LYR1.57%Amplitude47.70Dividend TTM4.40P/B100Lot Size1.90%Div YieldTTM
Dexerials Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 30.29%27.18B | -0.91%105.2B | 29.26%24.48B | 7.21%31.12B | -8.54%28.74B | -22.10%20.86B | 10.92%106.17B | -19.74%18.94B | 5.36%29.03B | 29.76%31.42B |
| Cost of revenue | 13.33%11.84B | -7.82%47.93B | 8.23%11.37B | -2.08%13.24B | -12.59%12.87B | -21.11%10.45B | 2.91%52B | -16.14%10.51B | -6.15%13.53B | 18.80%14.72B |
| Gross profit | 47.32%15.34B | 5.72%57.27B | 55.44%13.11B | 15.30%17.88B | -4.97%15.87B | -23.06%10.41B | 19.88%54.17B | -23.80%8.44B | 17.97%15.51B | 41.27%16.7B |
| Operating expense | 0.32%5.56B | 8.98%23.85B | 16.52%6.35B | 4.80%6.07B | 8.65%5.88B | 6.08%5.55B | 18.01%21.88B | 5.99%5.45B | 22.60%5.79B | 22.14%5.41B |
| Selling and administrative expenses | --5.74B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -General and administrative expense | --5.74B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | --22M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total other operating income | --200M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 100.90%9.77B | 3.51%33.42B | 126.41%6.76B | 21.57%11.81B | -11.50%9.99B | -41.41%4.87B | 21.19%32.29B | -49.62%2.99B | 15.37%9.71B | 52.74%11.29B |
| Net non-operating interest income (expenses) | -1,511.76%-240M | 1,371.43%206M | 300.00%88M | 2,064.71%368M | -2,570.00%-267M | 213.33%17M | 134.15%14M | 320.00%22M | 312.50%17M | 9.09%-10M |
| Non-operating interest income | 53.13%49M | 213.79%273M | 184.62%111M | 57.14%55M | 733.33%75M | 700.00%32M | 987.50%87M | 1,850.00%39M | 1,066.67%35M | 350.00%9M |
| Non-operating interest expense | 1,826.67%289M | -8.22%67M | 35.29%23M | -1,838.89%-313M | 1,700.00%342M | -21.05%15M | 48.98%73M | 41.67%17M | 63.64%18M | 46.15%19M |
| Net investment income | -66.27%-3.36B | -50.88%28M | 78.68%-235M | -78.67%-2.02B | 90.00%57M | -93.95%-929M | 87.60%-45M | |||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -38.33%-166M | -42.57%-144M | -179.07%-120M | -380.95%-101M | 0 | |||||
| Income from associates and other participating interests | 25.00%5M | -31.25%11M | 600.00%10M | -81.25%3M | -6M | 100.00%4M | 103.71%16M | 99.35%-2M | 142.11%16M | 0 |
| Special income (charges) | 49.65%-285M | -26.04%-242M | 66.47%-56M | 59.66%-566M | 64.44%-192M | 95.77%-21M | 12.26%-186M | |||
| Less:Impairment of capital assets | ---- | 124.71%191M | 19.51%49M | ---- | ---- | 220.00%48M | -46.88%85M | 10.81%41M | -65.00%14M | -63.41%15M |
| Less:Other special charges | ---- | -81.45%87M | 33.81%186M | ---- | ---- | -94.74%8M | -54.95%469M | -53.82%139M | -98.47%7M | 0.00%171M |
| Less:Write off | ---- | -41.67%7M | ---- | ---- | ---- | ---- | -94.06%12M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 356.52%105M | 9.52%-19M | 50.00%63M | -87.57%23M | -121.21%-21M | -900.00%-48M | -20.63%50M | |||
| Income before tax | 104.81%9.54B | 1.02%29.94B | 135.92%6.48B | 1.21%8.85B | -10.21%9.94B | -34.08%4.66B | 24.62%29.63B | -46.97%2.75B | 18.17%8.75B | 63.01%11.07B |
| Income tax | 97.03%2.85B | -3.49%8.6B | 177.71%1.94B | -4.09%2.44B | -15.36%2.77B | -39.60%1.45B | 25.37%8.91B | -42.81%700M | 6.40%2.54B | 59.09%3.27B |
| Net income | 108.32%6.69B | 2.96%21.33B | 121.63%4.54B | 3.35%6.41B | -8.04%7.17B | -31.24%3.21B | 24.31%20.72B | -48.27%2.05B | 23.83%6.2B | 64.71%7.8B |
| Net income continuous operations | 108.32%6.69B | 2.96%21.34B | 121.63%4.54B | 3.39%6.41B | -8.04%7.17B | -31.26%3.21B | 24.31%20.72B | -48.26%2.05B | 23.79%6.2B | 64.71%7.8B |
| Noncontrolling interests | 0 | -234.29%-47M | 0 | -288.24%-32M | -100.00%-2M | -230.00%-13M | 35M | 9M | 17M | -1M |
| Net income attributable to the company | 107.48%6.69B | 3.37%21.38B | 122.61%4.54B | 4.19%6.45B | -8.03%7.17B | -30.82%3.22B | 24.09%20.69B | -48.50%2.04B | 23.47%6.19B | 64.73%7.8B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 107.48%6.69B | 3.37%21.38B | 122.61%4.54B | 4.19%6.45B | -8.03%7.17B | -30.82%3.22B | 24.09%20.69B | -48.50%2.04B | 23.47%6.19B | 64.73%7.8B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 110.34%38.9833 | 5.16%122.9033 | 116.03%26.19 | 5.56%36.9459 | -5.85%41.1766 | -28.76%18.5333 | 27.68%116.8733 | -44.73%12.1233 | 27.09%35 | 69.16%43.7333 |
| Diluted earnings per share | 110.88%38.9067 | 5.33%122.46 | 116.40%26.1267 | 6.11%36.9459 | -11.80%38.36 | -28.69%18.45 | 27.86%116.26 | -44.63%12.0733 | 27.33%34.82 | 69.34%43.4933 |
| Dividend per share | 0 | 66.67%33.3333 | 116.67%21.6667 | 0 | 16.67%11.6667 | 0 | 0.00%20 | 0.00%10 | 0 | 0.00%10 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |